Replimune Group, Inc.
For the period ended Mar 31, 2026. Filed Jun 29, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jun 29, 2026
REPL$22.26+3.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated statements of cash flows F-
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
| Year Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net loss | $(313,940) | $(247,297) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation expense | 32,272 | 35,044 |
| Depreciation and amortization | 3,332 | 3,502 |
| Operating lease, right-of-use-asset amortization | 771 | 683 |
| Finance lease, right-of-use-asset amortization | 2,428 | 2,428 |
| Net amortization of premiums and discounts on short-term investments | (2,545) | (8,947) |
| Impairment on property, plant and equipment | 188 | — |
| Noncash interest expense | 1,933 | 1,568 |
| Unrealized foreign currency transaction gains | (942) | (201) |
| Changes in operating assets and liabilities: | ||
| Research and development incentives receivable | 451 | 1,303 |
| Prepaid expenses and other current assets | (232) | (252) |
| Other non-current assets | — | (1,200) |
| Accounts payable | (4,939) | 9,941 |
| Accrued expenses and other current liabilities | 2,184 | 11,743 |
| Operating lease liabilities | (818) | (720) |
| Other non-current liabilities | (487) | 155 |
| Net cash used in operating activities | (280,344) | (192,250) |
| Cash flows from investing activities: | ||
| Purchases of property, plant and equipment and software capitalization | (4,223) | (6,687) |
| Purchase of short-term investments | (77,894) | (403,586) |
| Proceeds from sales and maturities of short-term investments | 392,960 | 386,477 |
| Net cash provided by (used in) investing activities | 310,843 | (23,796) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock, net of fees and offering costs | — | 155,728 |
| Proceeds from issuance of prefunded warrants to purchase common stock, net of underwriting fees and offering costs | — | 97,000 |
| Proceeds from issuance of common stock through ATM sales, net of offering costs | 31,147 | — |
| Proceeds from long-term debt | 35,000 | — |
| Principal payment of finance lease obligation | (736) | (599) |
| Proceeds from exercise of stock options and pre-funded warrants | 883 | 267 |
| Net cash provided by financing activities | 66,294 | 252,396 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1,112 | 315 |
| Net increase in cash, cash equivalents and restricted cash | 97,905 | 36,665 |
| Cash, cash equivalents and restricted cash at beginning of period | 112,822 | 76,157 |
| Cash, cash equivalents and restricted cash at end of period | $210,727 | $112,822 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid during the period for interest | 4,688 | $4,198 |
| Cash received (paid) for income taxes, net | 5 | (105) |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Purchases of property and equipment included in accounts payable and accrued expenses | 80 | 171 |
F - 8
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.